Clozapine Therapy and CYP Genotype

Dean L, Kane M.

2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Clozapine Therapy and CYP Genotype

Dean L, Kane M.

2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Clozapine Therapy and CYP Genotype

Dean L, Kane M.

2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Aripiprazole Therapy and CYP2D6 Genotype

Dean L, Kane M.

2016 Sep 22 [updated 2021 Feb 10]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Xanthine Derivatives

2020 Jul 18. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

Atomoxetine Therapy and CYP2D6 Genotype

Dean L.

2015 Sep 10 [updated 2020 Jun 29]. In: Pratt VM, McLeod HL, Rubinstein WS, Scott SA, Dean LC, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Severe hypomagnesemia associated with reversible subacute ataxia and cerebellar hyperintensities on MRI.

Boulos MI, Shoamanesh A, Aviv RI, Gladstone DJ, Swartz RH.

Neurologist. 2012 Jul;18(4):223-5. doi: 10.1097/NRL.0b013e31825bbf07.

Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease.

Wolz M, Hauschild J, Koy J, Fauser M, Klingelhöfer L, Schackert G, Reichmann H, Storch A.

Parkinsonism Relat Disord. 2012 Sep;18(8):994-7. doi: 10.1016/j.parkreldis.2012.05.011. Erratum in: Parkinsonism Relat Disord. 2013 Dec;19(12):1181. Koy, Jan [added]; Schackert, Gabriele [added].

Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome.

Schneider A, Ballinger E, Chavez A, Tassone F, Hagerman RJ, Hessl D.

Neurobiol Aging. 2012 Jun;33(6):1045-53. doi: 10.1016/j.neurobiolaging.2010.09.002.

A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).

Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R.

Mult Scler. 2012 Feb;18(2):219-28. doi: 10.1177/1352458511419700.

LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation.

Lorenzo-Betancor O, Samaranch L, Ezquerra M, Tolosa E, Lorenzo E, Irigoyen J, Gaig C, Pastor MA, Soto-Ortolaza AI, Ross OA, Rodríguez-Oroz MC, Valldeoriola F, Martí MJ, Luquin MR, Perez-Tur J, Burguer

Mov Disord. 2012 Jan;27(1):146-51. doi: 10.1002/mds.23968.

Validity and inter-rater reliability of inertial gait measurements in Parkinson's disease: a pilot study.

Esser P, Dawes H, Collett J, Feltham MG, Howells K.

J Neurosci Methods. 2012 Mar 30;205(1):177-81. doi: 10.1016/j.jneumeth.2012.01.005.

L-DOPA changes spontaneous low-frequency BOLD signal oscillations in Parkinson's disease: a resting state fMRI study.

Kwak Y, Peltier SJ, Bohnen NI, Müller ML, Dayalu P, Seidler RD.

Front Syst Neurosci. 2012 Jul 4;6:52. doi: 10.3389/fnsys.2012.00052.

Ropinirole does not affect plasma arginine vasopressin levels in patients with advanced Parkinson's disease.

Arai M.

Neuro Endocrinol Lett. 2012;33(7):680-3.

Cervical dystonia after ear surgery.

van Gaalen J, Pennings RJ, Beynon AJ, Münchau A, Bloem BR, van de Warrenburg BP.

Parkinsonism Relat Disord. 2012 Jun;18(5):669-71. doi: 10.1016/j.parkreldis.2011.10.004.